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1 
XXiLANATORY  MEMORANDUM 
In  1986. the  Council  adopted  a  Resolution  on  a  pro1ramma  of  action of  the 
European  Communities  on  toxicology for  health protection  (OJ  C 184/1  and  2 of 
23  July  1986),  involving  a  eyatematic  review  of  the  role  and  functioning  of 
poison centres  in order to develop  the uae  of clinical toxicology data  (acute 
and  chronic) within  the  framework  of  an  overall  •••esament  of  the  impact  of 
chemical  products  and  preparations  on  human health,  as well  u  .to  promote  the 
exchange  of expertiae and  information  between  Member  Statu on  toxicolos:ical 
data. 
Acute  intoxications  in man  constitute a  medical  challenge  and  a  serious 
public health problem  in tha Community.  A serious  public  health problem  in 
that  the  causes  of  intoxications are  diverse,  constantly  increasin&  in 
number,  and  able  to circulate freely  in the  Community.  The  latter aspect will 
become  even  more  applicable when  the  Single Market  is established  in  1993. 
The  poison centres  of  one  country are  not  necessarily  in a  position to 
identify the  toxic  substances contained  in preparations  fr-om  another Member 
State.  Another  serious  cause  for  concern  is the possibility of  a  major 
poisoning diaaater where  diaanosis may  be  easy,  but  the  lara•  ~umber of 
paraona  affected  (worker•  and  Members  of  the public)  may  ea~8.·prpblom• vith 
the  supply  of  antidotes. 
Acute  intoxications  represent  a  medical  challen1e  in that the  poiaon centres 
Yhich  are  then contacted must,  in the vast majority of  cases,  reply 
immediately  by  telephone  to often badly  formulated  questions  from  members  of 
the  public,  as well  as  from  medical  staff,  They  must  then make  a  diaanosis  on 
the  baaia  of  the  information  given.  and  may  also have  to preecribe treatment. 
.  '• 
It vas  in this light that the  Commission  carried out  a  major survey  on  the 
functioning  of  poison centres  in the  Community  and  aant  a  questionnaire  on 
the availability of  antidotes to  the Member  States. 
From  the  replies  it emerged  that there  ia  a  certain amount  of  dispa~itr in 
how  the  poison centres process  queations  and  info~ation on  1ntcxicat1ons.  It 
was  also  found  that  even  specialized institutions were  relatively  ignorant  of 
some  of  the  less commonly  used  antidotes. 
.  ' 
The  Commission  is  therefore  proposing  a  aeries of  measures  to harmonize  the 
collection of  data  and  annual  reports and  to  improve  the availability of 
antidotes,  paying  special attention to  the border  zonas  of  the Member  States, 
where  trade  is more  intensive  and  information more  necessary  • 
.  \. 2 
'l'hu• meuuree will help  "to promote  throuahout  the  Community  a  harmonious 
development  of  economic  activities ...•.  and  cloaar relations  between  the 
States belongins  to  it"  (Article  2 of  the  BEC  Treaty)  by  ant1~1patinc an4 
reducing  the  possible effects of  certain preparations containins potentially 
danaeroua  substances  on  the  health of workers  and  the  public. 
bl!l~.OF TijE  DRAFT.  HESOLUTION 
This  Draft.  Resolution  should  11\1\ke  lt (IORHibJ.e  to prevent.e.nd  t.reat.  acute 
poiaonlng  in  a  more  effeetlve way  on  the  basis  of  tbe  exper\ence of  the  polRon 
centres;  it providoa  for  the  following: 
hflrmontzed  coUec:.tion  and  Aummar.izin&  of  informat.ion; 
cooperat.\.on  between  t.he  pohon eentru  \n  ar.etlR  lldj~acenl;  t.o  ot.her.  He111.ber 
st.at:es; 
the  improvement  of  the  ava,leblJ.lty ot  antLdotea; 
' 
ua:eumen  I.  at.  Gomtnun ity  lP.v~l  of  st.eps  taken  tl)  ~~reven't ·&cute  po \son l ns. 
It: would  be  de11ir.llbl.e  to hBvo  t.he  opin\on  of  t;he  European  Par.He.ment. 
The  Scientific Advisory committee  responsible  for.  ezaminin&  the tozic\ty  and 
ecotoxlcity of  chemical.  c0111.p0unds  expreaBed  a  favourable  oplnion on  +.he 
harmonized  annual  reports  (1). 
(1)  oJ·  No-·L  198,  22.Qf7e.  p.  17 
OJ  No  L  lOS.  26.04.88,  £1.  29 
• 
• 
•. • 
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COUNCIL  RESOLUTION 
ON  IMPROVING  THE  PREVENTION  AND 
TREATMENT  OF  ACUTE  HUMAN  POISONING 
THE  COUNCIL  OF  THE  EUROPEAN_COMKUNITIES, 
Having  regard  to  the Treaty establishing the  European  Economic  Community, 
Having  regard  to  the  Draft.  Reso]ut:ion  submitted by the Commission-(1), 
Having_  regard  to  the opinion of the  European  Parliament  (2), 
Having  regard to  the opinion of the  Economic  and  Social Committee  (3), 
Whereas,  for  a  policy  aimed  at preventing  the  riBks  of acute  poisoning  in  the 
population  and,  in particular,  runong  workers,  it is desirable  to  have  the 
maximum  amount  of  comparable  data on  clinical toxicology at Community  level; 
Whereas  each  poison  centre  in  the  Community,  by  virtue of  its  informational, 
therapeutic  and analytical functions,  is  one  of  the  bodies  in  the best 
position to collect clinical  toxicology data  in  its geographical  area of 
activity and  to process  this  information; 
Whereas  a  har.monizat.ion  of  the procedures  for.  collecting clinical toxicology 
data for all the  poison  centr.es  in  the  Commun\t:y  would  facilitate the 
development  of  a  policy for.  t:oxic  risk pr.evenHon; 
Whereas,  by  fostering  the  integration of clinical and  analytical data,  the 
Community  wishes  to  achieve  one  of  the main  objectives of its programme  of 
action  on  toxicology  for.  healt.h  protection  {4),  namely  to  help ensure  the 
quality  and  comparability of data  and  encourage  the  exchange  of experience  and 
information  in  the  field of clinical toxicology; 
(].) 
(2) 
(3) 
(4)  OJ  No  C  184,  23.07.1986,  pl. - 4  -
Whereas  harmonized  annual  reports will also  be  of value  in  the context of  the 
Council  Decision  of  22  April  1986  (86/138/EEC)  (5)  concerning  a  demonstration 
project with  a  view to  introducing  a  Community  system of  information  on 
accidents  involving  consumer  products,  which  stipulates  in  Annex  I 
(sub-section  2,  paragraph  3)  that  additional  information  may  be  obtained  from 
poison  centres  to  supplement  the  basic  information obtained from  the  casualty 
departments  of hospiLals; 
Whereas,  in  the  context.  of  l:he  free  movement  of persons  and  goods,  it is 
important  to  improve  the  availability of antidotes  by  facilitat.ing exchanges 
of  information  on  their availability,  in particular  in  areas  adjacent  lo other 
Member  states; 
Whereas  this Resolution  should help  to develop  t.he  use  of.  clinical toxicology 
data  in  overall  assessments  of the  impact  of  chemical  products  and 
preparations  on  lhe health of the  public  in  general  and,  more  particularly,  of 
workers  exposed  to dangerous  substances liable to cause  acute  poisoning, 
I 
Expresses  the political will  to  take  the  necessary steps  to  improve  the 
prevention  and  t:reatment of  acute  human  poisoning; 
II 
Invites  the Member  States: 
to designate  a  competent  authority so  that it may  take  the necessary 
measures  to  ensure that  the collection of call data and  the  annual 
reports  on  the work  of  the  poison  centres  and  the  associated  toxicology 
services  operating  in  the  territory of the Member  Stale concerned  are 
based  on  the  indications  set out:  in Annexes  l.  and  2; 
to  ensure  that antidotes,  i.e.  the  substances  and  preparations  used 
specifically  in  cases  of  acute  poisoning,  are  available on  the territory 
of  the Kember  State concerned; 
to  increase  the  practical  scope  for  using  antidotes  on  the  territory of 
the  Member  State concerned by  requiring  the  competent  authority to 
prepare  and  distribute a  list,  based  on  Annex  3,  of available antidotes 
for  treating acute  poisoning  cases  an~ of sources  of  supply,  so  that the 
recipients  have  at l:heir disposal  the  information  required to obtain 
these  antldotes within  the  period during  which  they can be  administered 
effectively; 
(5)  OJ  No  L  109,  26.04.86,  p  23 
• • 
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· t.o  provide  better emergency  services  i.n  areas  adjacent;  to other Member. 
States  by  arranging  for  the  relevant  competent  authorities,  in 
cooperation wHh  the  CommiRs ion,  to  set  up  between  the  poi son  centres  a 
Community  system of  information  and  collaboration  concerning  the 
availability of antidotes;  · 
to  arrange  for  the  competent  authority to  produce  a  summary  of  the 
harmonized  annual  reports of the  poison  centres  and  the  associated 
toxicology  servi.ces.  This  summary  wi 11  deal  in  particular with  records 
of  poisoning,  with a  note  on  the measures  taken  or.  planned by  the 
competent  authority to  improve  the  prevention  of  acute  poisoning,  and 
shall be  forwarded  to  the  Commission  before  31  March  of  the  following 
year,  together with  a  list of the  poison  centres  operating  on  their 
territory showing  the  areas  which  they  cover,  and  the 1\st: of available 
antidotes.  The  Commiuion  may,  where  necessary,  arrange  for.  all or.  part 
of  the  harmonized  annual  reports  to  be  forwarded  to  it.; 
III 
Invites  the Commission  t.o  arrange  for.  regular  summary  reports  to be  prepared 
for  the Community  indicating,  in  particular.,  the measures  required at·  · 
Community  level  for  the  prevention  of  acute  poisoning~  and  to expand  on 
specific  topics  based  on  the  information  received  from  the Member.  States on 
the  prevention  and  t.r.eatmenl  of  acute  poisoning; 
IV. 
Agrees  to review the provisions of  this  Resolut.ion  within  a  maximwn  period of 
five  years  following  its adoption,·on  the basis of  a  r.epor.t  from  the 
Commission. 
,· ··-!' 
~;. .,  . 
.  ':~  ·. 
..  ~  .  ·  .. : 
.... ,  ,. 
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AHHEX  1 
HARKONILED  CASE  DATA  RECORD  SHEET 
1 .  Cen~re code 
4.  4.1  Enquirer  :  Ha.e 
Address 
Tel  HUIIber 
4.2 Type  of enquirer 
4.2.1  Hospi~al  : 
2.  Call  registr~ion nuaber 
Recall  (  ) 
I  I  I  I  I  I  I  I  I  I  I  I· I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  ..  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I 
I  I  I  I  I  I  •  I  I  I  I  I  I  I  I  I  I  lo  e  I  I  I  I  I  I  ..;  I  I  I  I  I  I  I  I  I  I  ..  I  'I  I  I  I  I  I  I  I  I  I  I  I  I 
I  I  I  ..  I  I  I  I  I  I  I  I  I  I  I  I  I  I  1  I  I  I  I  I  I  1  I  I  I  I  I  I  I  I  I  I  I'  I  I  I  I  I  I  I  I  I  I  I  I  I  I 
I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I 
4.2.2 Ou~side hospi~al 
Acciden~ and  E•ergency  (Casualty)  c 
General  "edical  (  l 
)  Physicians  (  ) 
Nurses  C  ) 
In~ensive Care  (  )  Phar.acists (  ) 
Paediatric c  l  Veterinary surgeons  c  l 
Occupational  health services c  ) 
Industry/•anufacturers c  > 
E•ergency Services (  > 
Other  c  ) 
Unknown  (  ) 
Other Poisons Centres  (  )  General  Public  c  l 
"ass "edia  (  ) 
Authorities  (  ) 
Others  (  l 
UnkrKM~~n (  l 
5.  Type  of enquiry 
call  related to a  case c  l  Inforaation only  C  l  Other  (  )  Unknown  (  ) 
6.  Patient  6.1  "ultiple cases: Ves;  NUIIber:  ..... 
6 • 2  Hu.an  Nc111e  : .....................................................• 
6.2.1 
6.2.2 
6.2.3 
6.2.4 
6.2.5 
6. 3  Ani•al 
Age  Cyy ..  dd>  :  .................  ;  if esti•ated c  > 
Unknown  Child  (  )  Unknown  Adult  (  )  UnknoMn  (  ) 
Sex  :  "ale (  )  Fe•al e  C  ) 
Weight  cko>  :  .......... ;  if esti•ated <  l 
Pregnant:  Duration  Cweeksl  :  .........  . 
Lactating  :  yes  c  ) 
species  :  ................................  , ........................  . :) 
i. Agents 
7.1  Ha.e  (given  by  caller>: ...............  . 
Co•position of product: ...............  . 
"anufacturer  Cif relevant>  :  ..........  . 
Quantity  H0  :  •••  ;  Uol.  :  .....  ;  Wt. 
Unknown  c  > 
Exposure  Acute  C  >;  Chronic  c  > 
Frequency  :  Single  c  J;  Repeated  (  J 
7.2  Haae  (given  by  caller>  : ...............  . 
Co•position of product: ...............  . 
"anuf  acturer  c  if re  1  evant)  :  ..........  . 
Quantity  N°  :  ... ;  Uol.  :  .....  ;  Wt. 
Unknown  c  > 
Exposure  Acute  C  >;  Chronic c  ) 
Frequency  :  Single  c  >;  Repeated  C  ) 
7.3  Haae  Cgiven  by  caller>  : ...............  . 
Co•position of product: ...............  . 
"anufacturer  Cif relevant>  :  ..........  . 
Quantity  H0  :  •  •  •  ;  Uol.  :  ..... ;  Wt. 
Unknown  c  > 
Exposure  Acute  c  ) ;  Chroni c  c  l 
Frequency  :  Single c  >;  Repeated  c  ) 
7.4  Haae  Cgiven  by  caller>  : ...............  . 
Co•position of product: ...............  . 
"anuf  acturer  C  if relevant>  :  . ·  .........  . 
Quantity  H0  :  •  •  •  ;  Uo 1 •  :  . • • . .  ;  Wt. 
Unknown  C  > 
Exposure  Acute  C  >;  Chronic  c  ) 
Frequency  :  Single  c  >;  Repeated  c  ) 
7.5  Ha.e  Cgiuen  by  caller>  : ....  ~ .........  .. 
co.position of  product=··········~····· 
•  •  •  •  •  •  •  •  •  •  •  •  •  •  •  ·•  •  a  •  •  •  • • •  •  •  ·•  •  •  •  •  •  •  •  •  •  •  •  •  •  • 
"anufacturer Cif relevant>  :  ..  ~ .......  . 
Quantity  H 0  :  •• ~  ;  UOl.  :  .....  ;  Wt. 
Unknown  (  > 
Exposure  Acute  c  ) ;  · Chroni c  c  ) 
Frequency  :  Single  C  >;  Repeated  C  ) 
Classification of product 
Annual  Poisons 
Report  Centre 
. .....  ,  if esti•ated c 
. .....  ,  if esti•ated c 
.  ........ . 
. . . . . . ,  if esti  •ated c 
......  ' 
.............. 
. •••.••  if esti•ated ( 
7.6  Tiae since exposure  ............ Cddhhaa> 
. . .  : . 
..  ·.  ~ 
) 
) 
) 
) 
) 8.  location 
0.1  Hone  and  surroundings  C  ) 
8.2 Workplace  : 
- 8  -
Factory/workshop  c  > laboratory  c  )  Agriculture/horticulture  c  ) 
Other  c  ) 
8.3 co-unity 
Hursery or pri•ary school  C  )  Other school,  univ,  educational 
establis~ent C  )  Hospital,  clinic,  nursing ho•e  C  ) 
Institution  :  prison, •ilitary,  etc  c  >  Other  C  l 
8.4  Enclosed  public spaces  c  )  8.5 Open  places  C  ) 
8.6 Other  C  )  8.7 Unknown  c  ) 
9.  Circu.stances 
9.1  Accidental/Unintentional  9.2  Intentional  9.3  Adverse  reaction 
General  c  l 
Occupational  c  > 
Environ•ental  c  ) 
Transport Accident  c  ) 
Fire c  ) 
Therapeutic error  c  ) 
"isuse  c  ) 
Other  c  > 
Unkn0111n  c  ) 
9.4 UnknoMn  c  ) 
10.  Route of exposure 
10.1 
10.2 
10.3 
10.4 
10.5 
10.6 
10.7 
10.8 
10.9 
10.10 
10.11 
Ingestion c  > 
Inhalation  C  ) 
Cutaneous  c  ) 
Eye  contact c  ) 
Bite  c  ) 
Sting c  ) 
Injection 
Subcutaneous  C  ) 
Intra.uscular c  ) 
Intravenous  c  > 
Intra-arterial  C  ) 
"ucosal 
Buccal  c  ) 
Hasal  c  l 
Rectal  c  ) 
Vaginal  c  ) 
Placental  c  ) 
Other 
Unknown 
Suicide  (  )  Drug  c  ) 
"isuse  (  )  Food  <  ) 
Abuse  c  )  Other  c  ) 
"alicious/criainal  (  ) 
Other  C  ) 
Unknown  c  ) 
. ·- !,.· 
T 
t  ,. 
~  . 
:· .() 
• 
- '_;; 
·11.  Signs  and  syaptoas 
11.1  Signs  and  syapto•s  present 
11.2  Signs and  sy•ptoas not  present 
11.3  unknown 
Poisons Centre free text  :  I  I  1  •  I  e  1  I  I  e  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  1  I  I  I  I  I  I  I  I  I  I  I  I  1 
Poisons Centre  local  syapto• code  : 
I  I  I  I'·'  I  I  I  I  I  .•  I  I  I  I  I  I  I". I  I  I  I  I  I  I  I  I.  1'1  I  I  1  f' 
12.  Toxicological  analysis  yes  .c  >;  ...•....••..••..••..•••..••...•...••• 
13.  other i nvesti gati  ons  yes  c  >;  ......................................  . 
I  I  I  I  I  I  I  I  I  I  I  I  I  I. I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  I  • 
14.  Treataent ·-·  :  Treat•ent. carried- · Treat•ent reco.•ended . 
out  before  enquiry  by  PC 
14.1  Hone  (  )  (  ) 
Prevention of absorption  : 
Gastric eMptying  :  Eaesis  (  )  (  ) 
Lavage  (  )  (  ) 
Activated charcoal  (  )  (  ) 
Syapt011atic  treataent  (  )  (  ) 
Eliaination  (  )  (  ) 
Life support  proceedures  (  )  (  ) 
Antidote therapy  (  )  .  (  ) 
Other  (  )  (  ) 
14.2  Place of treataent 
Treat&ent  at ho•e or at place of incident,  not  by  physician  ) 
Treataent outside hospital  by  a  physician  C  > 
Treataent in hospital  c  >  other  c  > 
15.  Estiaated·risk  :  non-toxic  c  > 
Probably  non-toxic. now  toxi city/•i niaal  exposure> 
Poisoning  not  excluded  C  >  · Predi ct  ab  1  e  risk  c 
Syeptoas  unl'e 1  ated to exposure  c.  ) 
16.  Outc011e  : 
(  . ) 
) 
Co•pl ete recovery  c  >;  sequelae  <  >;  death  c  >;  unklle*n  c  > 
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ANNEX  2 
LAYOUT  OF  THE  HARMONISE_D  ANNUAL  REPORTS 
1.  Id~nt!fication of the_body  drafting  the  report 
Name;  full  address  (indicating  country);  telephone,  telex  and  fax 
numbers  (if any);  name  of  person  in  charge  of centre. 
2.  Year 
The  year covered  by  the annual  report  in question. 
3.  Administrative  information on  the  centre 
Description of  staff at centre  (medical  and  administrative  personnel);  a 
brief description of the centre's work;  the  size of  the  population  served. 
4.  Calls  to  the centre 
The  total  number  of calls,  their monthly  variation,  their distribution 
according  to  the  person  making  the  request,  the  way  in which  the  call  is 
made  (telephone,  letter,  etc.),  the  reasons  (actual  or  presumed 
poisoning,  simple  request for  information,  etc.). 
5.  Poisoning  cases 
the  number  of  cases  and  the  frequency  should  be  indicated for each 
category  or  sub-category; 
- if the  centre  has  the  necessary  resources,  it would  be  desirable  to 
. break  down  the data  in  terms  of  the classes of aetiological agents 
listed  below. 
5.1  Cases  involving  human  beings 
males,  females  (including  pregnant  women,  nursing  mothers),  unspecified 
Age  groups  (in years):  <  1 
1  4 
5  - 9 
10  - 14 
15 - 19 
20- 69 
> 70 
unknown 
.. 
.  •.{ ~ 
~· ' . 
,: 0 
.  -
--
.~  ., 
...  11  --
- Aetiological agents: 
non--pharmaceutical  chemical  substances  (simple  or compound.- natural 
or synthetic): 
-·  industrial 
- pesticides 
- household  products 
others 
pharmaceutical  substances  (human  or veterinary)  . 
animal~ as  such  (whether  by  their venom  or through  consumption  of 
poisonous  meat  - e.g.  ichthyosarcotoxism - where  chemical  products, 
bacteria or putrefaction are not  the·cause) 
plants as  such. (including hallucinogenic or poisonous  mushrooms) 
·others  (including  toxins  of  bacterial origin,  e.g.  botulism) 
not  identified 
- Location: 
home  and  immediate-surroundings 
workplace  :  industry 
agriculture/horticulture 
.  other 
· public  establishments  (e.g.  schools  or training centres,_ government 
offices,  post· o'ffices, 1 ibraries,  public  transport - trains,  buses, 
underground  railways,  etc  .. ) 
enclosed  public  places  (e.g.  bars,  discotheques,  restaurants, 
shopping  centres, ·department  stores,  etc.) 
open  places  (e.g.  sports grounds,  children• s  playgrounds,  etc.) 
other or unknown 
-Circumstances: 
accidental  acute  poisoning 
deliberate acute  poisoning 
side effect of drugs 
accidental chronic  poisoning 
deliberate  chronic poisoning 
other or unkown - Initial evaluation: 
non--toxic 
probably  non-toxic 
poisoning  not  excluded 
predictable risk 
established  poisoning 
- 12  -
symptdms  unrelated  to  the  exposure 
-- Treatment: 
none 
symptomatic  only 
specific  (antidote  therapy). 
-- Outcome 
complete  recovery 
hospitalization  (number  of days) 
sequelae 
death 
unknown 
5.2  Animals 
6.  Record  of poisoning  cases 
Draw  up a list of the fifteen  most  frequent  causes  of  poisoning  in 
decreasing  order of frequency  (indicating the  number  of calls),  with a 
breakdown  by  age  group. 
7.  Record  of requests  for  information 
Draw  up  a  list of the  fifteen  products  for which  most  requests for 
information are  received. 
8.  Record  of toxicological analyses 
Drc'..J  up  a  list of the fifteen  toxicological analyses  which are most 
frequently  requested  by  the  centre. 
9.  Comments  in free  text 
On  all treatment given  and  information provided;  on  particularly 
interesting cases  which  may  have  been  encountered,  on  other activities 
(teaching, _research,  etc.)  and  on  any  other aspect  not  included  elsewhere. 
10.  Conclusions 
These are to deal  mainly  with  the  impac-tof.the centre's activities on 
prevention. 
.  \ 
I' 
J 
'  \ • 
1:' 
ANNEX  3 
ANTIDOTE 
- 13  -
MAIN  INJ),ICATIONS.  AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  J.N  TREATMENT 
.  .  '  .  .  .  .  . 
----------·~-------.. ----·~---··------·-----~---------·--·-.-----·. 
Acetylcysl:eine 
Amyl  nitrite· 
Antivenins  and  antoxins 
Atropine 
Benzylpenicillin 
Calcium gluconate 
Calcium  sodium  edet.ate 
(EDTA) 
Dantrolene 
Deferoxamine 
Diazepam 
Dicobalt Edetate 
Digoxin  specific 
antibody  fragments 
(FAB) 
Paracetamol 
Chloroform 
Carbon  tetrachloride 
Acrylonitrile 
Cyanide 
Cholinergic  syndrome 
Amatoxins 
Hydrofluoric  acid 
Fluorides 
Oxalates 
I.e ad 
Malignant  Hypert~hermla 
Malignant Neuroleptic  Syndrome 
Iron 
Aluminium 
Seizures 
Chloroquine 
Cyanide 
DigoxiD 
Dig~·t.o~in.  . ....  ·> 
Digitdis:Glucosides 
A:  required to be  i~ediately availab~e <within  30  tili~ut:.es) 
B:  re.quired  to  b~ available within  two· h'ours: 
C:  required· to available within':'  six hoq.rs: 
~ 
.. 
':.· 
'· .·1·;: 
·-·  ... 
B 
B 
B 
B 
A 
A-C 
A 
B 
A 
A 
A 
B 
A 
A 
B 
B 
A 
s· 
·B 
<'B 
........ (  · ..  , 
t  .·•  :. 
. .  •.; 
. ·  ... , S~'ECIHC ANTIDoTES  .. 
Dimercaprol  (BAL) 
4-Dimethylaminophenol 
(4-DKAP) 
Diphenhydramine 
Ethanol 
Etybenzatropine 
Flumazenil 
FoHnic  Acid 
Glucagon 
Hydrosocobalamin 
(Vit.  Bl2a) 
Methionine 
4-Kethylpyrazole 
Kethylthioninium 
chloride 
(Methylene  blue) 
N-Acetyl  penicillamine 
Nalosone 
Neostigmine 
Osimes 
Osygen 
Osygen  hyperbaric 
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MAIN  INDICATIONS 
ArBenic 
Gold,  inorganic mercury 
Lead  encephalopathy 
Cyanide 
Drug-Induced dysLonias 
Methanol 
Ethylene  glycol 
Drug-induced dystonias 
Benzodiazeplnes 
folic Acid  Antagonists 
-blockers 
Cyanide 
Paracetamol 
Ethylene  glycol 
Methanol 
Methaemoglobinaemia 
Mercury  (organic  Bnd 
metallic) 
Opiates 
Neuromuscular  block 
(curare  type) 
AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  IN  TREATMENT 
B 
B 
R 
A 
A 
A 
A 
A 
B 
A 
A 
B 
A 
A 
A 
c 
A 
A 
Peripheral  ant-.icholinergic  A 
poisoning 
Organophosphates  B 
Carbon  monoside  A 
Cyanide  A 
Hydrogen  sulphide  A 
Carbon monodde  c 
Cyanide  c 
Hydrogen  sulphide  c 
Carbon  tetrachloride  c 
t 
•-) 
- l.S  -
SPECIFIC  ANTIDOTES  MAIN  INDICATIONS  AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  IN  TREATMENT 
·----·---------··-·---·-----------------·-------·-·-----------------------· 
O-Pen i c i llamine 
Pentetic Acid  (DTPA) 
Diethylenetriamine 
pentaacetic  acid 
Phento.lami. ne 
Physostigmine 
Phytomenadione  (Vit:  K) 
Potassium ferric 
hexacyanoferrate 
(Prussian  Blue) 
Prenalterol 
Prot~ine sulphate 
Pyridoxine  (Vit.B6) 
Silibinin 
Sodium  nitrite 
Sodium  thiosulphate 
Succimer  (DMSA) 
2.3  Dimercaprol 
succinic acid 
Tolonium Chloride 
(Toluidine Blue) 
TrienHne 
( Tri  ethylene  t.etrami  ne  ). 
Unitiol  (DKPS) 
2.3  Dimer.capto-1-
propanesulphonic  acid 
Copper. 
Gold,  Lead,  Mercury 
(elemental)  Zinc 
Plutonium,  actinides 
Alpha-adrenergic  poisoning 
Central  anticholinergic 
syndrome  from 
- atropine  and  derivatives 
- other drugs 
Coumarin  and  lndanedione 
anticoagulants 
Thallium 
-blockers 
Heparin· 
Isoniazid 
Crimi dine 
Ethylene  glycol 
Gyromit;rin 
Hydrazines 
Amatoxins 
Cyanide 
Cyanide 
Lead 
Mercury  (inorganic  and  organic) 
Arsenic  ~· 
Hethaeinoglol;>inaemia 
._.; 
Copper 
c 
c 
c 
A 
A 
A 
A 
8 
B 
A 
A 
A 
B 
B 
B 
B 
B 
A 
A 
B 
B 
··B 
.A 
:B 
Mer_~\11'~- .  <met:hyl~. ar;d  in()rs&:nJ~.>  . '··  , B : ···  · 
.. - ..  ·  .. 
·  ..  ·.  ..  -.:  •  .·  B  : 
-... :  :- :  ~:  , ..... 
·.  ~;·  . 
.. ·. 
··:. 
/:.:, 
, .. 
'.: ...  ~  ' 
•:':·;·  ;,  ··:· 
,. 
- .:--' '  ·~. 
., 
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B.  AGENTS  TO  PREVENT  ABSORPTION  OF  TOXIC  SUBSTANCES  IN  THE  GASTROINTESTINAl. 
TRACT 
ANTIDOTE 
Activated charcoal 
Cholest.yr.amine 
Fullers  EA.rth 
Potassium ferr.ocyanide 
Sodium  bicarbonate 
Sodium  sulphate 
Starch 
ANTIDOTE 
Calcium gluconah gel 
Macrogol  400  (PEG) 
Copper.  sulphate,  sodium 
bicarbonate,  hydr.oxy-
ethylcel.lulose 
D.  ~TICS 
ANTIDOTE 
Apomorphine 
T.pecacuanba 
MAIN  INDICATIONS 
(for. most  poisonings) 
Digitalis,  Coumarin 
Chlordecone 
ParA.quat,  Diquat. 
Coppet" 
tron 
Organophosphates 
Barium 
Iodine 
MAIN  INDICATIONS 
Hydrofluoric  acid 
Phenol 
White  Phosphorus 
MAIN  INDICATIONS 
AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  IN  TREATMENT 
A 
8 
A 
A 
A 
A 
A 
A 
AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  IN  TREATMENT 
---------------------
A 
A 
A 
AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USE  IN  TREATMENT 
A 
A 
{ ) 
- l.7  -
ANTIDOTE  MAIN  INDICATIONS  AVAILABILITY  IN  TERMS  OF 
URGENCY  OF  USI  IN  TREATMENT 
. -----------·  ----,--------·--------------·  -···-
Magnesium  citrBte 
Magnesium  sul.phBte . 
Mannit-.ol 
Sodium  sulphBte 
Sorbitol 
··  Whole  gut:· lavage  fluids · 
(Polyethylene  glycol 
elect.r_olyte  <  lBvage 
solution 
ANTIDOTE 
Ammonium  chloride 
Arginine hydrochloride 
~ydrocbloric acid  (0.1  N) 
Sodium  bicarbonate 
MATN  INDICATIONS 
8 
. - 8 
B 
8 
8 
· ··IS 
AVAILABILtTY  IN  TERMs  OF 
URGENCY  OF  USE  IN  TRIATlmNT 
·-----------~---
B 
B 
.B 
A 
~ .. ,  ~ 
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A  2511:  Meetings  of  committees  whose  consultation  is not.  compulsory 
8  6475:  Toxicology action  programme 
A) 
b) 
Non-compulsory. 
4.1 
The  TreAties  of  the  European  Communities. 
Resolution  of the Council  And  the  representatives of 
the  Governments  of the  Member  Stales,  meeting within 
the  Council  of  29  Kay  1986,  on  a  programme  of act:ion 
of  the  EuropeAn  Communities  on  toxicology for health 
protection  (OJ  No  C 184  of  23.7.1986,  p.l). 
The  Resolution  on  improving  lhe  prevention  and  treatment of acute 
poisoning  is  intended to meet  three objectives: 
proposing  common  forms  for  the various  poison 
centres  in  the Community  with  a  view to  improving 
the  comparability  and  use  of the clinical data 
collected; 
facilitating the collection of clinical toxicology 
data,  which  is an  essential prerequisite for  a  full 
evaluation of health  risks.  The  reliability of the 
information extrapolated from  animal  data to humans 
requires further  study; 
impr.oving  the availability of antidotes within  the 
Community  by  increasing knowledge  on  their 
indications  and  by  providing an  incentive for  the\r 
distribution. ' 
4;2  Jus~ification 
The  acllon is justified by  th(l  legal bases  s.iven  in  point 2.  The  financial 
implicationa will be  associated with  the measures  set out.  in point  S. 
5.  Nature  of the  expenditure  and  method  of  calculation 
5.1  Nature of.tbe  additional activities tp  be  undertaken  tollowin&  the 
adoption  of the  Resolution 
a)  Manltotins  the  i~plementatlon of the aesolutlon in the  individual 
M•~mbcr stat.os •  ' ·  , . 
• 
b)  consult.a·ti'on  ~it.h- exp~r.t.'s;' 
·, 
C)  consultation of'  the Scienllfic Advisory  Co~lttee set.  up  to exaEAlne  the 
to,ieily and  ecotoxiclty of  che~ical compounds; 
d)  eomputecizat.ion  of data. 
Tbes(l  are: 
.....  :- ..  . .... 
Study  and/or  service  c9ntrac~s undertaken·in -~rder:t~: 
..  . ': .· 
·•. ·  .. ·  ·  ...  ~ ...... :: .·  '··:'  :. 
>· 
.  compare  and  evaluate  t.he  information _uceived bf t,be  Coll!lllfa.ai.o.n  · · ... 
.  .  ..  .  <):  :.;:  ·>·~·::  __  ._:... 
,  1\:.Udy  t.ho  problems  auoci&t.ed With  the  pract;Leal  impleine,ntatfon>·.a~d .··:t-;·:·: 
effect.i van&sa  of  the aesolut.ion  · ·  ....  ·~·,':.· >  :·,.  ·  ·  :.  .. .. :  . 
.  computerize  the  lnfo~ma~\on collected 
.  ' 
Cost.s  of consultation meetln&•  with  ezpe~t.s. 
.  .. ·  •'  ';  ..  ···,  .. 
\,," 
'  .·  .. 
.. 
operating  expenses  of. the  Sc\e_ni;.U'~e Advlsorr COlllllllt.t.ee  set. up  to  . 
examine  the  tozicity and  ecotozic1t.y of  chemical. compound~.  ~on•ls~ln& 
of 12  non-·Gove·rnmont  experts "\'Aeetln&  t.h:ee  times  per ·ye,c-·, ·  ..  · ·  ... 
•  •  •• '•  4  ....  ', 
~.3 Calculatlon of expenditure  . .  ,.  I,  •'  ',  .. 
'.• 
.  •'  .. ·· .... 
.  .  . 
Althou&h  only th'  natu~a and  t.Jpe .of  the. a~dit~onal actlvii;.Let  are  k~o~. 
wlt.h  no  indication of their acale,  it:.  shoul_d·  be  poa.llble .t.o  1tea9  actual 
expendlt.ut'e  within  t.he  llalt.• set out· in 6  below.  · ·  ·  · ·  ' 
th~ cost  oC  con venin&  a  non-:Governn\ent  expert it nt.baatecl at ·62,5.  ECU. · 
.  •.  .....  _. 
'  ...  .~·  •  I  . 
.. :·:-::.:t ... 
·.· ..  . - ~  .· . 
'  ,'· . 
. .·.·: ·  . 
.·_.·_ ... 
.. ·.  · .. 
;  ' . 
. .... •.::. 
'. 
'·  •·. Cosls  are calculalod on  the  basis  of  the  ~man/monlh" unit;  at pretent,  one 
unil  is .equivalent  to  5  000  RCU. 
The  expendilure will  be  spread  over  several  yeacs  and  will  be  procresslve. 
The  fisures  &lven  in 6.1 are  approxi~ate estimates. 
6.  Financial  impact  of  the  action on  intervention  apergpriatloga 
6.1 Schedule  of commitment  apPropriations  and  psrment  appropriation& 
ltem A 2511 
1989 
l990 
1991 
1992 
1993 
Tota.l. 
lhtn B 6475 
1989 
1990. 
1991 
1992 
1993 
Total 
I' 
• 
CA  (RCU) 
, .. 
25  000 
25  000 
25  000 
25  000 
25  000 
125  000 
CA  (ECU) 
.50  000  ·so  ooo 
100 000 
100  000 
100 009 
4oo  ooo 
PA  (KC':U) 
25  000 
25  000 
25  000 
25  000 
. 25  090. 
125  000 
6. 2  ror the  work  provided  for  ln  the Draft aesolyUon,·· \ht. COIIJ9hdon ·w{uu:, .. : 
provide 100'1.  tund\.p&  . .  · ·  ·· .. · · ·  · · · · 
.  . .  .  . .  .  ·~  ..  ;  .. :' .  ~:  ·' . .  ~ . 
7 , ·  Remarks 
s. 
None. 
FinaDelal  impact  on  staff tpproprlations 
! 
.~ 
.  ... 
I  ~  ,  '  ••  '  , '  ...  •  I 
.  ' . . . 
8.1 'Personnel needed  solely for ·the  actl9p itaetr·  .....  ' 
.4  •• •  .•  :·  • 
.  :~ ·.  ' 
As  fr:om  1990.  one  half-time A offlchl. one  balf~·tlme B  of£l~hl  ·and  one  · ·  .  .  ·.  •.  .. .. 
half-time c  offlcial will be  needed.  .  .  .'::  ·-,.:  . ·.· \  · · ...  ',. 
·~  .. '•  ~..  .  . .  . .  .;_ 
The  allocatlon  of  these  t'&Soureu  w\ l1 depend  on  th; .  poet's  ·~d  .. :.· .  ~:.;_.:  .''·i;.  , 
appropriations  authorized  in  the  budget.  and  on  the  scope ··ror.. red.Pl()rment .·. · 
of posts  and  1taff mobility. 
8.2  Appropriations  ne~ded for staff 
The  estimated  appt'opriatlons  needed as 
,' 
.  ··'·  . 
'  •;::  :.  '':  • :,:•  ••  ·,  ';  •  :  :  . ••  ....  I  '  •  ~ • ,·  • 
.  . .  .  ..  :··  .  -~.~: -~·  :-;.::~~-.;~:- ·-~: 
from  1990 ·&r.-1~·~:  00~~:;~~.·~~~={·~~:.~  .. >··.;::;·,.· .. 
,. 
I  .. 
'•,  o;  '  ,!''  ••,,  ••' • 
!. 
I 
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ASSESSMENT  OF  IMPACT 
ON  COMPETITIVENESS  AND  EMPLOYMENT 
\ 
'\\: 
Draft Council  Resolution  on  improving  the  prevention  and  lreatmen.l \)f: acute 
\·,  . 
poisoning.  0 
;~ \ 
\I 
1,',_ 
1.·  The  main  aim of  the  Draft Council  Resolution  is  to harmonize  the '~a.ll  data 
forms  and  the  annual  reports  and  to facDitate the distributi_on  of)' 
antidotes  SO' as  to  provide  an  incentive  at. Community- level for  the\;poison 
centres· to work -together  to  improve  the  services  they  prov-ide .to  us.l;irs  and. 
·:.  to prevent  acute  poisoning more  effectively.  .  '. 
2.  ·The Draft·council  Resoluti:on  applies  t;o  all poison  centres  in  the 
\  ·. 
----··-.. -------------------------Gommun-it.y-.-----------------,---------..  -------------------------------------~--------------·-· .....  _________  ...... __ ....  __ .. __________________  .  ___ ... 
3.  The  measures  t.o  be  taken  by  the  poison centres  in' applying. t_his  Resolution 
will ·entail  adapting  and  harmonizing existing .measures,  and  thet'efore 
should-not  lead  to  any  major  financial const  .. l'aints  on  public. service . 
bodies,  whi'ch  operate out.side  t.he  sphet'e  of. economic  competition. 
4.  The  measures  taken  by  the Kember  St.ates  to facilitate  the distribution of 
ant.idotes  should  eventually lead  to  a  r.educt.ion  in  t:heir .costs . ISSN 0254;.1475 
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